英文名稱 |
中文名稱 |
CAS號 |
操作 |
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7-tosyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
N-甲基-N-((3R,4R)-4-甲基-1-芐基-3-哌啶基)-7-((4-甲基苯基)磺酰基)7H-吡咯并[2,3-D]嘧啶-4-胺 |
923036-30-0 |
詳細(xì)
|
N-((S)-1-(((R)-1-hydroperoxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
硼替佐米雜質(zhì)K |
886979-78-8 |
詳細(xì)
|
N-((S)-1-(((S)-1-hydroperoxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
硼替佐米雜質(zhì)K |
886979-81-3 |
詳細(xì)
|
N-(2-(DiethylaMino)ethyl)-5-forMyl-2,4-diMethyl-1H-pyrrole-3-carboxaMide |
N-(2-(二乙基氨基)乙基)-5-甲?;?2,4-二甲基-1H-吡咯-3-甲酰胺 |
356068-86-5 |
詳細(xì)
|
N-(2-chloro-6-Methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-MethylpyriMidin-4-yl)aMino)thiazole-5-carboxaMide |
達沙替尼 |
302962-49-8 |
詳細(xì)
|
N-(2-diethylaMinoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)Meth yl]-2,4-diMethyl-1H-pyrrole-3-carboxaMide |
舒尼替尼 |
557795-19-4 |
詳細(xì)
|
N-(2-Pyrazinecarbonyl)-D-phenylalanine-D-leucine boronic anhydride |
硼替佐米雜質(zhì)L |
1132709-16-0 |
詳細(xì)
|
N-(2-Pyrazinecarbonyl)-D-phenylalanine-L-leucine boronic anhydride |
硼替佐米雜質(zhì)-異構(gòu)體 |
1132709-15-9 |
詳細(xì)
|
N-(2-Pyrazinecarbonyl)-L-phenylalanine-D-leucine boronic anhydride |
硼替佐米雜質(zhì)E |
1132709-14-8 |
詳細(xì)
|
N-(Trans-4-(4-(cyclopropylMethyl)piperazin-1-yl)cyclohexyl)-4-(((R)-7-ethyl-8-isopropyl-5-Methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)aMino)-3-MethoxybenzaMide |
N-[反式-4-[4-(環(huán)丙基甲基)-1-哌嗪基]環(huán)己基]-4-[[(7R)-7-乙基-5,6,7,8-四氫-5-甲基-8-異丙基-6-氧代-2-蝶啶基]氨基]-3-甲氧基苯甲酰胺 |
755038-65-4 |
詳細(xì)
|
N-[2-(diethylaMino)ethyl]-2,4-diMethyl-1H-pyrrole-3-carboxaMide |
N-(2-(二乙基氨基)乙基)-2,4-二甲基-1H-吡咯-3-甲酰胺 |
590424-05-8 |
詳細(xì)
|
Nilotinib iMpurity A |
|
|
詳細(xì)
|
Nilotinib iMpurity B |
|
|
詳細(xì)
|
Nilotinib iMpurity C |
|
|
詳細(xì)
|
Nilotinib iMpurity D |
|
|
詳細(xì)
|
N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 |
477600-74-1 |
詳細(xì)
|
N-PYRAZINYLCARBONYLPHENYLALANINE METHYL ESTER |
硼替佐米雜質(zhì)G |
73058-37-4 |
詳細(xì)
|
Olaparib iMpurity A |
奧拉帕利雜質(zhì)A |
|
詳細(xì)
|
Olaparib iMpurity B |
奧拉帕利雜質(zhì)B |
|
詳細(xì)
|
Olaparib iMpurity C |
奧拉帕利雜質(zhì)C |
|
詳細(xì)
|
Olaparib iMpurity D |
奧拉帕利雜質(zhì)D |
|
詳細(xì)
|
Riociguat iMpurity-1 |
|
|
詳細(xì)
|
Riociguat iMpurity2 |
|
|
詳細(xì)
|
Riociguat iMpurity-2-1 |
|
|
詳細(xì)
|
Sunitinib iMpurity A |
Sunitinib iMpurity A |
|
詳細(xì)
|
Sunitinib iMpurity B |
Sunitinib iMpurity B |
|
詳細(xì)
|
Sunitinib iMpurity C |
Sunitinib iMpurity C |
|
詳細(xì)
|
Sunitinib iMpurity D |
Sunitinib iMpurity D |
|
詳細(xì)
|
Sunitinib iMpurity E |
舒尼替尼雜質(zhì)E |
|
詳細(xì)
|
Sunitinib iMpurity F |
舒尼替尼雜質(zhì)F |
|
詳細(xì)
|
tert-butyl ((S)-4-Methyl-1-((R)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)carbaMate |
((1S)-3-甲基-1-(((2R)-2-甲基環(huán)氧乙基)羰基)丁基)氨基甲酸叔丁酯 |
247068-82-2 |
詳細(xì)
|
tert-butyl 4-[[[2-(diethylaMino)ethyl]aMino]carbonyl]-3,5-diMethyl-1H-pyrrole-2-carboxylate |
舒尼替尼中間體3 |
590424-04-7 |
詳細(xì)
|
Trans-4-?[4-?(cyclopropylMethyl)?-?1-?piperazinyl]?-?cyclohexanaMine hydrochloride (1:?) |
反式-4- [4-(環(huán)丙基甲基)-1-哌嗪基] - 環(huán)己烷鹽酸鹽(1 :) |
876371-19-6 |
詳細(xì)
|
Volasertib iMpurity A |
|
|
詳細(xì)
|
1-BOC-4-(6-AMINOPYRIDIN-3-YL)PIPERAZINE |
4-(6-氨基-3-吡啶基)-1-BOC-哌嗪 |
571188-59-5 |
詳細(xì)
|
tert-butyl (3-bromo-5-(trifluoromethyl)phenyl)carbamate |
|
641571-03-0 |
詳細(xì)
|
4-chloroquinolin-8-amine |
4-氯-8-氨基喹啉 |
81764-16-1 |
詳細(xì)
|